CTX — Captor Therapeutics SA Share News
0.000.00%
Last trade - 00:00- PLN371.04m
- PLN302.20m
- PLN4.66m
Brief: Captor Therapeutics Q3 Net Loss Narrows To 8.5 Mln Zlotys
Brief: Captor Therapeutics Signs Cooperation Deal With Japan-Based Ono Pharmaceutical
Brief: Captor Therapeutics Informs About Nomination Of Candidate For CPT-6281 Drug Under CT-01 Project
Brief: Captor Therapeutics Q1 Net Loss Widens To 11.0 Mln Zlotys
Brief: Captor Therapeutics Sees Potential Delays In The Implementation Of CT-03 Project
Brief: Captor Therapeutics Obtains Results Of Additional In-Vivo Tests Regarding CT-01 Project
Brief: Captor Therapeutics Makes Progress In Cancer Treatment Development
Brief: Captor Therapeutics Informs NCBiR Of Potential Irregularities In EU Project Costs
Brief: Captor Therapeutics Says Preclinical Proof-Of-Concept Trial Results Confirm High Anti-Cancer Activity Of Two Compounds
Brief: Captor Therapeutics To Issue 30,738 Shares As Part Of Incentive Scheme
Brief: Captor Therapeutics Updates On Developments In CT-03 Project
Brief: Captor Therapeutics Appoints Radoslaw Krawczyk As Director For Finance